Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-18

FDA Approved: VASOPRESSIN — Original Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Amphastar Pharmaceuticals' generic vasopressin product through an Original Application (ANDA). This allows marketing of a vasopressin injectable fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

ORIG AP for VASOPRESSIN (VASOPRESSIN)